Cart

This article PDF is available for purchase only. PDFs are free for members! Become a member and save today

Remove item Thumbnail image Product Price Quantity Subtotal
× Placeholder The Pharmacokinetics of Sertraline Excretion Into Human Breast Milk: Determinants of Infant Serum Concentrations PDF $40.00
$40.00
× Placeholder Metabolic Depression: A Chronic Depressive Subtype? Findings From the InCHIANTI Study of Older Persons PDF $40.00
$40.00
× Placeholder The Economic Burden of Depression in the United States: How Did It Change Between 1990 and 2000? PDF $40.00
$40.00
× Placeholder Estrogen Augmentation of Antidepressants in Perimenopausal Depression: A Pilot Study PDF $40.00
$40.00
× Placeholder Responsibility PDF $40.00
$40.00
× Placeholder Lithium Treatment Effects on the Neuropsychological Functioning of Patients With Bipolar I Disorder PDF $40.00
$40.00
× Placeholder Second-Generation Antipsychotic-Induced Hypoglycemia PDF $40.00
$40.00
× Placeholder Citalopram in the Treatment of Binge-Eating Disorder: A Placebo-Controlled Trial PDF $40.00
$40.00
× Placeholder A Case of Multisystem Organ Failure in a Patient With Inhalant Use Disorder PDF $40.00
$40.00
× Placeholder A Case of Acute Heart Failure Probably Associated With Venlafaxine Use PDF $40.00
$40.00
× Placeholder Time Trends in Incidence Rates of Diagnosed Attention-Deficit/Hyperactivity Disorder Across 16 Years in a Nationwide Danish Registry Study PDF $40.00
$40.00
× Placeholder Obesity, Dyslipidemia, and Diabetes With Selective Serotonin Reuptake Inhibitors: The Hordaland Health Study PDF $40.00
$40.00
× Placeholder Juvenile Maladaptive Aggression: A Review of Prevention, Treatment, and Service Configuration and a Proposed Research Agenda PDF $40.00
$40.00
× Placeholder Why Do You Need to Move Beyond First-Line Therapy for Major Depression? PDF $40.00
$40.00
× Placeholder Sertraline Treatment of Posttraumatic Stress Disorder: Results of 24 Weeks of Open-Label Continuation Treatment PDF $40.00
$40.00
× Placeholder Identification of High-Risk Coronary Heart Disease Patients Receiving Atypical Antipsychotics: Single Low-Density Lipoprotein Cholesterol Threshold or Complex National Standard? PDF $40.00
$40.00
× Placeholder The Treatment of Sedative-Hypnotic Dependence: Evaluating Clinical Predictors of Outcome PDF $40.00
$40.00
× Placeholder Lamotrigine Rechallenge in Treatment-Resistant Bipolar Disorder PDF $40.00
$40.00
× Placeholder Psychotropic Medications in Swedish Homicide Victims and Offenders: A Forensic-Toxicological Case-Control Study of Adherence and Recreational Use PDF $40.00
$40.00
× Placeholder Opium Withdrawal Presenting as Recurrent Vomiting PDF $40.00
$40.00
× Placeholder Understanding of Lockdown Among Adolescents and Youth With Intellectual Disabilities PDF $40.00
$40.00
× Placeholder Response Acceleration With Mirtazapine Augmentation of Citalopram in Obsessive-Compulsive Disorder Patients Without Comorbid Depression: A Pilot Study PDF $40.00
$40.00
× Placeholder Applicability of Telemedicine for Assessing Patients With Schizophrenia: Acceptance and Reliability PDF $40.00
$40.00
× Placeholder A Randomized, Double-Blind, Placebo-Controlled Trial of Desvenlafaxine Succinate in Adult Outpatients With Major Depressive Disorder PDF $40.00
$40.00
× Placeholder Quantifying the Impact of Patient-Practice Relationship Quality on the Levels of the Average Annual Antidepressant Practice Prescribing Rate in Primary Care in England PDF $40.00
$40.00
× Placeholder Transcranial Magnetic Stimulation for Medication-Resistant Depression PDF $40.00
$40.00
× Placeholder Aripiprazole in Children and Adolescents With Bipolar Disorder Comorbid With Attention-Deficit/Hyperactivity Disorder: A Pilot Randomized Clinical Trial PDF $40.00
$40.00
× Placeholder Easy and Low-Cost Identification of Metabolic Syndrome in Patients Treated With Second-Generation Antipsychotics: Artificial Neural Network and Logistic Regression Models PDF $40.00
$40.00
× Placeholder Depressive and Anxiety Disorders Predicting First Incidence of Alcohol Use Disorders: Results of the Netherlands Study of Depression and Anxiety (NESDA) PDF $40.00
$40.00
× Placeholder Personality and the Long-Term Outcome of First-Episode Depression: A Prospective 5-Year Follow-Up Study PDF $40.00
$40.00
× Placeholder The Relationship of Personality Disorders to Treatment Outcome in Depressed Outpatients PDF $40.00
$40.00
× Placeholder Venlafaxine Versus Placebo in the Preventive Treatment of Recurrent Major Depression PDF $40.00
$40.00
× Placeholder Use of Antipsychotics in the Treatment of Major Depressive Disorder in the U.S. Department of Veterans Affairs PDF $40.00
$40.00
× Placeholder Genetic Studies of Drug Response and Side Effects in the STAR*D Study, Part 2 PDF $40.00
$40.00
× Placeholder Self-Inflicted Hammer Blows to the Cranial Vault: An Interdisciplinary Challenge PDF $40.00
$40.00
× Placeholder Thinking About Dying and Trying and Intending to Die: Results on Suicidal Behavior From a Large Web-Based Sample PDF $40.00
$40.00
× Placeholder Extrapyramidal Symptoms and Tolerability of Olanzapine Versus Haloperidol in the Acute Treatment of Schizophrenia PDF $40.00
$40.00
× Placeholder Vaccine-Induced Psychosis as an Etiology to Consider in the Age of COVID-19 PDF $40.00
$40.00
× Placeholder Predicted Risk of Diabetes and Coronary Heart Disease in Patients With Schizophrenia: Aripiprazole Versus Standard of Care PDF $40.00
$40.00
× Placeholder Genetic Studies of Drug Response and Side Effects in the STAR*D Study, Part 1 PDF $40.00
$40.00
× Placeholder Randomized Clinical Trial of Brief Primary Care–Based Mindfulness Training Versus a Psychoeducational Group for Veterans With Posttraumatic Stress Disorder PDF $40.00
$40.00
× Placeholder Mortality and Suicide Related to Major Depressive Disorder Before and After Type 2 Diabetes Mellitus PDF $40.00
$40.00
× Placeholder Suicide Prevention and Schizophrenia PDF $40.00
$40.00
× Placeholder An International Consensus Study of Neuroleptic Malignant Syndrome Diagnostic Criteria Using the Delphi Method PDF $40.00
$40.00
× Placeholder Effectiveness of Aripiprazole, Olanzapine, Quetiapine, and Risperidone Augmentation Treatment for Major Depressive Disorder: A Nationwide Population-Based Study PDF $40.00
$40.00

Instead of purchasing individual articles, subscribe to our membership plan and get unlimited access to all article PDFs from both of our journals.


Join Now

Cart totals

Subtotal $1,800.00
Total $1,800.00
Proceed to checkout

Consensus Report on XT Use in Practice

Read the full report
Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe